280 likes | 357 Views
Explore the incidence rates of various cancers in NY State during 1981-1994, with a specific emphasis on Kaposi's sarcoma. Learn about herpesvirus taxonomy, detection of KSHV in Kaposi's sarcoma, and mother-to-child transmission in South Africa. Delve into cellular homologues in the KSHV genome and reasons for the response of Kaposi's sarcoma to ART. Discover the roles of KSHV immune reconstitution, cellular immune response restoration, and angiogenesis inhibition in combating AIDS-related cancers.
E N D
NY State AIDS Cancer Incidence (1981-1994) Kaposi’s sarcoma 97.5 NHL 37.4 Liver primary 5.1 Skin, non-KS 20.9 Hodgkin’s disease 8.0 Melanoma 1.4 Rectum and Anus 3.3 Cervix 9.1 Colon 0.8 Breast 0.8 Prostate 0.7 Ovary 0.8 Am J Epid 2001, 154: 544-556
Herpesvirus taxonomy HVS KSHV/HHV-8 EBV HSV-1 HSV-2 VZV HHV-7 HHV-6 HCMV
Detection of KSHV in Kaposi's Sarcoma Whitby et al.,JNCI, 1999
SOUTH AFRICA MOTHER-TO-CHILD TRANSMISSION Age of children, years MOTHER STATUS0-4 5-9 10-14 All KSHV seropositive 29% 29% 80% 42% KSHV seronegative 0% 0% 13% 1% Bourboulia et al., JAMA 1998, 280: 31 NEJM 1999, 341:1241
Cellular Homologues in the KSHV Genome Cellular proliferation v-Cyclin D v-GPCR v-IRF Apoptosis inhibitors v-bcl-2 v-FLIP v-IL-6 Chemokines v-MIP1 v-MIP2 v-MIP3 >15% of the viral genes are pirates from the eukariotic cellular DNA
Naïve B-cell KSHV KSHV EBV or EBV +KSHV Memory B-cell EBV MCD (KSHV) GLD (KSHV + EBV) BL (EBV) Germinal Centre PEL (KSHV) PEL (KSHV + EBV) Plasma cell PERIPHERY TONSIL EBNA-1+ LANA1+ vIL-6+ vIRF1+ EBNA2+, LMP1, 2+ LANA1+ vIL6+
Reasons for Response of KS to ART ACTION MECHANISM KSHV immune reconstitution KSHV CTLs target and kill KSHV infected spindle Restoration of cellular immune response cells Reduction of HIV-1 Tat and other Cytokines involved in the stimulation of KS inflammatory cytokine levels angiogenesis (eg. bFGF) Protease inhibitor (PI) based regimens PI has been shown to block KS spindle cell growth have a direct anti-spindle cells and and KS-induced angiogenesis in experimental anti-angiogenic effect models